» Articles » PMID: 18300044

Nasal Uptake of Inhaled Acrolein in Rats

Overview
Journal Inhal Toxicol
Publisher Informa Healthcare
Specialty Toxicology
Date 2008 Feb 27
PMID 18300044
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

An improved understanding of the relationship between inspired concentration of the potent nasal toxicant acrolein and delivered dose is needed to support quantitative risk assessments. The uptake efficiency (UE) of 0.6, 1.8, or 3.6 ppm acrolein was measured in the isolated upper respiratory tract (URT) of anesthetized naive rats under constant-velocity unidirectional inspiratory flow rates of 100 or 300 ml/min for up to 80 min. An additional group of animals was exposed to 0.6 or 1.8 ppm acrolein, 6 h/day, 5 days/wk, for 14 days prior to performing nasal uptake studies (with 1.8 or 3.6 ppm acrolein) at a 100 ml/min airflow rate. Olfactory and respiratory glutathione (GSH) concentrations were also evaluated in naive and acrolein-preexposed rats. Acrolein UE in naive animals was dependent on the concentration of inspired acrolein, airflow rate, and duration of exposure, with increased UE occurring with lower acrolein exposure concentrations. A statistically significant decline in UE occurred during the exposures. Exposure to acrolein vapor resulted in reduced respiratory epithelial GSH concentrations. In acrolein-preexposed animals, URT acrolein UE was also dependent on the acrolein concentration used prior to the uptake exposure, with preexposed rats having higher UE than their naive counterparts. Despite having increased acrolein UE, GSH concentrations in the respiratory epithelium of acrolein preexposed rats were higher at the end of the 80 min acrolein uptake experiment than their in naive rat counterparts, suggesting that an adaptive response in GSH metabolism occurred following acrolein preexposure.

Citing Articles

Sex-specific respiratory and systemic endocrine effects of acute acrolein and trichloroethylene inhalation.

Alewel D, Jackson T, Vance S, Schladweiler M, Evansky P, Henriquez A Toxicol Lett. 2023; 382:22-32.

PMID: 37201588 PMC: 10585336. DOI: 10.1016/j.toxlet.2023.05.005.


Molecular Binding Contributes to Concentration Dependent Acrolein Deposition in Rat Upper Airways: CFD and Molecular Dynamics Analyses.

Xi J, Hu Q, Zhao L, Si X Int J Mol Sci. 2018; 19(4).

PMID: 29584651 PMC: 5979435. DOI: 10.3390/ijms19040997.


Respiratory Effects and Systemic Stress Response Following Acute Acrolein Inhalation in Rats.

J Snow S, McGee M, Henriquez A, Richards J, Schladweiler M, Ledbetter A Toxicol Sci. 2017; 158(2):454-464.

PMID: 28541489 PMC: 6515527. DOI: 10.1093/toxsci/kfx108.


Janus-faced Acrolein prevents allergy but accelerates tumor growth by promoting immunoregulatory Foxp3+ cells: Mouse model for passive respiratory exposure.

Roth-Walter F, Bergmayr C, Meitz S, Buchleitner S, Stremnitzer C, Fazekas J Sci Rep. 2017; 7:45067.

PMID: 28332605 PMC: 5362909. DOI: 10.1038/srep45067.


Sedative effects of inhaled essential oil components of traditional fragrance Pogostemon cablin leaves and their structure-activity relationships.

Ito K, Akahoshi Y, Ito M, Kaneko S J Tradit Complement Med. 2016; 6(2):140-5.

PMID: 27114936 PMC: 4833466. DOI: 10.1016/j.jtcme.2015.01.004.